Tissue Regenix Group PLC Company Profile (LON:TRX)

Analyst Ratings

Consensus Ratings for Tissue Regenix Group PLC (LON:TRX) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 40

Analysts' Ratings History for Tissue Regenix Group PLC (LON:TRX)
Show:
DateFirmActionRatingPrice TargetActions
7/12/2016Beaufort SecuritiesReiterated RatingSpeculative BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2016Jefferies GroupBoost Price TargetBuyGBX 35 -> GBX 40View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015Panmure GordonReiterated RatingBuyGBX 29View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Tissue Regenix Group PLC (LON:TRX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Tissue Regenix Group PLC (LON:TRX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Tissue Regenix Group PLC (LON:TRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tissue Regenix Group PLC (LON:TRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Tissue Regenix Group PLC (LON:TRX)
DateHeadline
07/29/16 03:39 AMTissue Regenix Group Plc breached its 50 day moving average in a Bearish Manner : TRX-GB : July 29, 2016 -
07/28/16 07:19 PMTissue Regenix : Edison research outlook on Tissue Regenix (TRX)
07/28/16 07:19 PMTissue Regenix Group: Strong Outlook In Orthopaedics
07/21/16 05:09 AMTissue Regenix to feature via Discovery Channel -
07/18/16 03:27 PMTissue Regenix Group Plc – Value Analysis (LONDON:TRX) : July 18, 2016 -
07/16/16 06:14 PMTissue Regenix stands out as tendon technology shows movement in regulatory process
07/15/16 12:12 PMTissue Regenix: Pig tissue and cutting-edge medical science
07/12/16 03:43 AMTissue Regenix Group Plc breached its 50 day moving average in a Bullish Manner : TRX-GB : July 12, 2016 -
07/11/16 06:48 PMTissue Regenix Makes OrthoPure Progress In Europe And US
07/11/16 06:48 PMDouble dose of regulatory good news for Tissue Regenix
07/11/16 01:13 AMOrthopaedics Update - [at noodls] - Tissue Regenix Group plc - Positive discussion with FDA regarding regulatory approval routes - Initial clinical evidence renders OrthoPure™ XM biocompatible - CE Mark application for OrthoPure™ XT brought ...
07/05/16 08:24 AMTissue Regenix Appoints Orthopedic Clinical Advisory Board in the US -
07/03/16 07:49 AMTissue Regenix Group chief hopes US DermaPure deal is first of many
07/01/16 01:21 AMDermaPure® secures first GPO contract in US - [at noodls] - Tissue Regenix Group plc York, 1 July 2016 - Tissue Regenix Group (AIM:TRX) ('Tissue Regenix' or 'The Group') the regenerative medical devices company announces that Tissue Regenix Wound Care, Inc. has ...
06/30/16 09:39 AMTissue Regenix : Deferred Annual Bonus Scheme
06/30/16 09:39 AMTissue Regenix Group ( TRX )
06/24/16 03:53 AMTissue Regenix Group Plc breached its 50 day moving average in a Bearish Manner : TRX-GB : June 24, 2016 -
06/14/16 03:47 AMTissue Regenix Group Plc breached its 50 day moving average in a Bearish Manner : TRX-GB : June 14, 2016 -
06/01/16 07:39 PMTissue Regenix adds long-time medical advisor to the board - Regenerative medical technology specialist Tissue Regenix Group PLC (LON:TRX) has beefed up its board with the appointment of Professor Shervanthi Homer-Vanniasinkam. The professor, a respected consultant vascular surgeon, joins as a non-executive director.
06/01/16 01:13 AMNew appointment adds clinical expertise to Board - [at noodls] - Tissue Regenix Group plc Leeds, 1 June, 2016 - Tissue Regenix Group (AIM:TRX) ('Tissue Regenix' or 'The Group') the regenerative medical devices company today announces that it has appointed Professor ...
05/27/16 05:07 AMPreliminary results for year ended 31 January 2016 - [at noodls] - Tissue Regenix Group plc Leeds, 23 May 2016 - Tissue Regenix Group (AIM:TRX) ('Tissue Regenix' or 'The Group') the regenerative medical devices company, today announces its unaudited preliminary results ...
05/23/16 06:07 AMFull Year 2016 Tissue Regenix Group PLC Earnings Release - Time Not Supplied -
04/15/16 02:00 PMTRX changes registered office - StockMarketWire.com - Tissue Regenix (TRX) has announced that the Company's Registered Office has changed to Unit 1 & 2, Astley Way, Astley Lane Industrial Estate, Swillington, Leeds LS26 8XT with immediate effect.
04/14/16 01:00 PMClinical posters further validating the use of Tissue Regenix DermaPure® to be displayed at SAWC conference -
03/14/16 09:00 AMBroker Forecast - Jefferies International issues a broker note on Tissue Regenix Group PLC - Jefferies International today reaffirms its buy investment rating on Tissue Regenix Group PLC (LON:TRX) and raised its price target to 37p (from 36p). Story provided by StockMarketWire.com
03/14/16 09:00 AMTissue Regenix Group PLC making progress on all fronts – Jefferies - Regenerative medtech Tissue Regenix Group PLC (LON:TRX) is making clear progress on all fronts, said heavyweight US broker Jefferies today, which rates the shares a 'buy'. The group is a wound care expert, with its Dermapure product being used to rebuild ...
02/12/16 12:17 PMTissue Regenix Group plc ( - Appointment of Vice President of Tissue Regenix Orthopaedic, Inc. North America York, 11 February 2016 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix") or ("The Group") the regenerative medical devices company, is pleased to announce the ...
02/11/16 12:07 PMVP, Orthopaedic, Inc. North America appointed - York, 11 February 2016 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix") or ("The Group") the regenerative medical devices company, is pleased to announce the appointment of Drew Distin as Vice President ("VP") of the Group's recently established ...
02/03/16 10:59 AMDermaPure to be Showcased in Nine Posters at SAWC - York, 03 February 2016 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix") or ("The Group") the regenerative medical devices company, is pleased to announce Tissue Regenix Wound Care, Inc. will display nine poster presentations at the Symposium on ...
01/27/16 10:49 AMDermaPure® breaks through $1m sales mark - [at noodls] - Tissue Regenix Group plc ('Tissue Regenix' or 'The Group') York, 20 January 2016 - Tissue Regenix Group plc (AIM:TRX) ('Tissue Regenix' or 'The Group') the regenerative medical devices company announces ...
01/26/16 11:10 AMTissue Regenix to market heart valves through German venture - Tissue Regenix (LON:TRX) has agreed a joint venture in Germany that will use ... will invest €250,000 to fund development and distribution. A new joint venture company, GBM-V, will be set up and prepare the regulatory submissions to the German authorities.
01/26/16 11:10 AMTissue Regenix Group (TRX) - In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States - 'Tissue Regenix Wound Care Inc.', as part of its commercialisation strategy for its dCELL® technology platform.
01/21/16 09:33 AMTissue Regenix Group Plc – Value Analysis (LONDON:TRX) : January 21, 2016 -
01/21/16 03:30 AMTissue Regenix Group Plc breached its 50 day moving average in a Bullish Manner : January 21, 2016 -
01/20/16 10:12 AMProactive news highlights - Tissue Regenix, Kromek and Collagen Solutions - Woundcare specialist Tissue Regenix (LON:TRX) saw shares rise over 9% as it has reached another ... but remains upbeat over prospects overall. The group is developing a range of collagen-based medical implants such as cartilages. Due to the delays, it ...
01/20/16 10:12 AMDermaPure breaks through $1m sales mark - York, 20 January 2016 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces its dCELL® woundcare product DermaPure® has now surpassed the $1m sales mark, following its ...
01/20/16 04:45 AMTissue Regenix Group strengthens Board with Non-Executive appointment - [at noodls] - Tissue Regenix Group plc ('Tissue Regenix or 'The Group') York, 19 January 2016 - Tissue Regenix Group plc (AIM:TRX) ('Tissue Regenix') or ('The Company') the regenerative medical devices company, is pleased ...
01/19/16 09:48 AMTissue Regenix Appoints Consort Medical CEO As Non-Executive Director - LONDON (Alliance News) - Regenerative medical devices company Tissue Regenix Group PLC on Tuesday said it has appointed the chief executive of Consort Medical PLC as a non-executive director. Jonathan Glenn has been the CEO at Consort, an AIM-listed ...
01/19/16 02:55 AMOrthoPure™ XM clinical trial enrolment completed - [at noodls] - Tissue Regenix Group plc ('Tissue Regenix' or 'The Group') York, 18th January - Tissue Regenix Group plc (AIM:TRX) ('Tissue Regenix' or 'The Group'), the regenerative medical devices company, announces ...
01/18/16 09:45 AMUPDATE - Tissue Regenix completes enrolment process - Regenerative medical devices specialist Tissue Regenix (LON:TRX) has ticked another box, completing the enrolment process for its OrthoPure XM clinical trial. The company said 20 patients have been signed up for a trial that is required to complete the ...
01/18/16 09:45 AMOrthoPureT XM clinical trial enrolment completed - York, 18th January - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "The Group"), the regenerative medical devices company, announces it has now enrolled in its OrthoPure™ XM (porcine meniscus) clinical trial the 20 patients required to ...
07/30/15 06:00 AMTissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure -
07/30/15 01:39 AMTissue Regenix extends product availability through new distributor agreement - [at noodls] - Tissue Regenix Group plc (AIM:TRX) ('Tissue Regenix' or 'The Group'), the regenerative medical devices company, announces that TRX Wound Care Inc. has signed an additional regional distribution agreement ...
07/22/15 04:10 AMTissue Regenix Group plc - Extends product availability through new distributor agreement - [at noodls] - Portfolio news 2015 22 Jul 2015 York, 22 July 2015 - Tissue Regenix Group plc (AIM:TRX) ('Tissue Regenix' or 'The Group'), the regenerative medical devices company, announces that TRX Wound Care Inc. has ...
07/22/15 02:20 AMFurther Medicare Coverage Approval for DermaPure® - [at noodls] - Tissue Regenix Group plc (AIM:TRX ) ('Tissue Regenix' or 'the Group'), the regenerative medical devices company, today announces it has secured approval from the Noridian Healthcare Solutions and Palmetto ...
06/26/15 07:44 AMListen to Tissue Regenix CEO, Antony Odell, Speak at the Jefferies 2015 Healthcare Conference in New York - [at noodls] - On 04 June, Tissue Regenix CEO, Antony Odell, addressed an audience at the Jefferies 2015 Healthcare Conference in New York, introducing Tissue Regenix and talking about recent milestones and outlook. ...
06/26/15 04:42 AMTissue Regenix Group gains further Medicare approval for DermaPure -
06/26/15 04:04 AMTissue Regenix Group plc - Further Medicare Coverage Approval for DermaPure® - [at noodls] - Portfolio news 2015 26 Jun 2015 Delivering on the strategy: DermaPure® now available to 20.7 million Medicare beneficiaries YORK, 26 June 2015 - Tissue Regenix Group plc (AIM:TRX) ('Tissue Regenix' or ...
06/04/15 08:31 AMDermaPure® saves 18 year old’s leg from frost bite & is featured on US TV Programme - [at noodls] - Tissue Regenix Group plc (AIM:TRX) ('Tissue Regenix' or 'the Group'), the regenerative medical devices company, announces that DermaPure®, which is used in the treatment of chronic and acute wounds, has ...
06/01/15 06:00 AMDermaPure® Saves 18 Year Old's Leg From Frost Bite & is Featured on US TV Programme - [PR Newswire] - YORK, England, June 1, 2015 /PRNewswire/ -- Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Group"), the regenerative medical devices company, announces that DermaPure®, ...

Social

About Tissue Regenix Group PLC

Tissue Regenix Group PLC logoTissue Regenix Group plc is a United Kingdom-based medical devices company. The Company is principally engaged in the exploitation of platform technologies in the field of tissue engineering and regenerative medicine. The Company has developed decellularisation (dCELL) technology, which removes DNA and other cellular material from tissue leaving an acellular scaffold which is not rejected by the patient's body. The applications of dCELL address critical clinical needs, such as wound care, vascular disease, heart valve replacement and knee repair. The Company has developed DermaPure, a human dermis product. The Company offers OrthoPure category products, including porcine meniscus products used to repair damage from tears in the meniscus knee cartilage and tendon products used for surgical reconstruction of a torn anterior cruciate ligament in the knee. In addition, the company offers CardioPure HV, a human heart valve product.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: TRX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.25
  • 50 Day Moving Average: $19.05
  • 200 Day Moving Average: $18.30
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $141.20M
  • Current Year EPS Consensus Estimate: $-1.51 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: